We bid a fond farewell to Dr Hilal Sarac who leaves the group this week for an exciting role as a senior scientist at Cancer Research UK, Target Discoveries Laboratory in the Francis Crick Institute in London. Hilal has been a credit to the group having made great process on the CRUK and ERC grants. She will certainly be missed. We asked her to reflect on her time in the Kawamura Lab, she said: I really enjoyed my time both as a visiting PhD student and then as a postdoctoral researcher at Kawamura group in Oxford and in Newcastle. Fortunately, my path crossed with several talented scientists who work in… Read More »Goodbye Hilal!
A warm welcome to Justina Heslop who joins us to support the group with reporting, events, social media and engagement. Justina has worked as a Research Project Manager at Newcastle University since 2017, supporting several research groups and projects across Chemistry and Engineering most notable the North East Centre for Energy Materials.
A warm welcome to our new PhD students who joined us on 1st October 2021. Emma Wadforth, Oliwia Rebacz, Tom Smith, and Tim Bell will be working across a number of exciting projects funded by BBSRC, EPSRC MoS Med CTD, ERC.
Many congratulations to Dr Benoit Darlot on successfully defending his DPhil thesis on Design of modulatory peptides against chemokines. As well as his sterling work on on tick protein derived anti-inflammatory peptides, Benoit was an active member of the research community. He was a member of the NU Rainbow Network steering committee and the committee for the NuTEC RSC local section where he endeavoured to support his local community and encourage young chemist to get their voices heard. It was great having Benoit as part of the team and we wish him every success as he embarks on his journey to train as a patent lawyer in London.
Welcome to our new research associate Marie-Helene Ruchaud who joins us from Newcastle University Medical School where she worked on a variety of projects involving innate immunology and inflammation. These included studying the human immune response in epithelial cells following Enteropathogenic E.Coli (EPEC) infection along with the regulation of the innate immune response in severe lung injury & infection or testing potential antimicrobial agents such as p97 inhibitors acting as DNaA inhibitors in Staphyloccocus aureus and Pseudomonas aeruginosa. She is currently developing quantitative cellular assays to investigate inhibition of SARS-Cov2 main protease by cyclic peptides. A warm welcome to the team!